• WITH SMES,

    INVEST IN OUR FUTURE
  • WITH SMES,

    INVEST IN OUR FUTURE
  • WITH SMES,

    INVEST IN OUR FUTURE

A targeted investment strategy

Xerys is a portfolio management company specialising in private equity with an approach that makes the entrepreneur’s vision central to its investment philosophy. It aims to support the managers of Xerys Funds portfolio companies at all stages of their growth, from venture capital to maturity.

JACQUES SIMONNET

JACQUES SIMONNET

Chairman of the supervisory board and founder

OLIVIER OSSIPOFF

OLIVIER OSSIPOFF

Chairman

OUR PHILOSOPHY

The Xerys approach

« The creation of Xerys aims to meet the need to reconcile two major issues for business growth. On the one hand, entrepreneurs who wish to successfully carry out their growth ambitions need tailored, financial guidance but also strategic and operational support. On the other hand, investors are looking for transparency and control of their investments.…


OUR STRATEGY

AN ORIGINAL APPROACH TO A CAPITAL INVESTOR

100%

INDEPENDENT


€10-60K

INVESTMENT
TICKET


12

PORTFOLIO
COMPANIES

2014

Approval of the Authority
Financial Markets

Strong expertise

The governance of Xerys Gestion is structured around a supervisory board and a directory with complementary experiences

Strong involvement

The management team and the experts are involved in the monitoring of the participations

Convergent interests

The management team is systematically interested in the performance of investments

Xerys therefore immediately establishes a constructive and proactive proximity relationship with the managers of its investments to assist and advise them in their strategic decision-making, arbitration and value creation.
With this original approach, Xerys establishes a relationship of trust with managers and investors, fostering a creation of shared value over the medium term.

3 SECTORS OF INVESTMENT


Santé


Sustainable
development


Connected
Technologies

NEWS

Alzprotect

Alzprotect strengthens its Intellectual Property Portfolio for its First-in-Class Clinical Stage Drug Ezeprogind

Lille (France), November 23rd, 2020 ALZPROTECT, a biopharmaceutical company developing therapeutic solutions for neurodegenerative diseases announces today that the United ...
Read more

Herow and Phenix win grand prizes at the «digilocales 2020» event

The campaigns resulting from the partnership between Herow and Phenix won the prize for the best geolocation device and the ...
Read more
Cryo Pur

Cryo Pur signs a new contract for a bio-LNG plant in Norway

On July 17th, Cryo Pur and Sunnhordland Naturgass (SNG) signed an agreement for the construction of a biogas upgrading and ...
Read more

Vehicles adapted to investor expectations


Participations via dedicated funds and/or mutual funds

OUR PARTICIPATIONS

Xerys

XERYS FRANCE

7 rue d’Aguesseau

75008 Paris - France

+33 (0)1 82 52 12 25

FOLLOW-US: